Abstract
Purpose
Maspin is a member of the serpin family and has tumor suppressor activity. We evaluated maspin expression in pulmonary adenocarcinoma in relation to a number of clinicopathological features.
Methods
Maspin expression was examined immunohistochemically in a series of 78 pulmonary adenocarcinomas by the EnVision ChemMate method.
Results
Thirty-seven of 78 cases (47%) showed distinct maspin expression (maspin-positive group) and 41 (53%) did not (maspin-negative group). Maspin expression was not associated significantly with most clinicopathological variables including sex, age, tumor size, primary tumor, lymph node metastasis, visceral pleural invasion, pulmonary metastasis, and disease stage. However, the maspin-positive group had a better 5-year survival rate (62%) than did the maspin-negative group (42%). The difference in the 5-year survival rate was greatest in stage II patients (maspin-positive group, 69%; maspin-negative group, 17%; P = 0.048).
Conclusion
Our data indicate that maspin has prognostic significance for pulmonary adenocarcinoma. A better understanding of the role of maspin in tumor suppression may be helpful for development of novel chemotherapies for patients with this deadly tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
American Joint Committee on Cancer (2002) Cancer staging handbook. TMN classification of malignant tumors, 6th edn. Springer, New York, pp 191–203
Bepler G, Goodridge Carney D, Djulbegovic B, Clark RA, Tockman M (2003) A systematic review and lessons learned from early lung cancer detection trials using low-dose computed tomography of the chest. Cancer Control 10:306–314
Boring CC, Squires TS, Tong T (1993) Cancer statistics. Cancer J Clin 43:7–26
Chiba Y, Taniguchi T, Matsuyama K, Sasaki M, Kato Y, Tanaka H, Muraoka R, Tanigawa N (1999) Tumor angiogenesis, apoptosis, and p53 oncogene in stage I lung adenocarcinoma. Surg Today 29:1148–1153
Hirabayashi H, Ohta M, Tanaka H, Sakaguchi M, Fujii Y, Miyoshi S, Matsuda H (2002) Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53. J Surg Oncol 81:177–184
Kuroishi T, Nishikawa Y, Tominaga S, Aoki K (1999) Cancer mortality statistics in 33 countries (1954–1992). Gann monograph on cancer research: cancer mortality and morbidity statistics, vol 47. Japan Scientific Societies, Tokyo Karger Basel, pp 153–217
Luppi M, Morselli M, Bandieri E, Federico M, Marasca R, Barozzi P, Ferrari MG, Savarino M, Frassoldati A, Torelli G (1996) Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene. Ann Oncol 7:619–624
Maass N, Hojo T, Ueding M, Lüttges J, Klöppel G, Jonat W, Nagasaki K (2001a) Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7:812–817
Maass N, Hojo T, Rosel F, Ikeda T, Jonat W, Nagasaki K (2001b) Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 34:303–307
Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K, Rudolph P (2001c) Decline in the expression of the serine proteinase inhibitor maspin is associated with tumour progression in ductal carcinomas of the breast. J Pathol 195:321–326
Machtens S, Serth J, Bokemeyer C, Bathke W, Minssen A, Kollmannsberger C, Hartmann J, Knuchel R, Kondo M, Jonas U, Kuczyk M (2001) Expression of the p53 and maspin protein in primary prostate cancer: correlation with clinical features. Int J Cancer 95:337–342
Ohike N, Maass N, Mundhenke C, Biallek M, Zhang M, Jonat W, Lüttges J, Morohoshi T, Klöppel G, Nagasaki K (2003) Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. Cancer Lett 199:193–200
Oh YL, Song SY, Ahn G (2002) Expression of maspin in pancreatic neoplasms: application of maspin immunohistochemistry to the differential diagnosis. Appl Immunohistochem Mol Morphol 10:62–66
Sasaki M, Sugio K, Kuwabara Y, Koga H, Nakagawa M, Chen T, Kaneko K, Hayashi K, Shioyama Y, Sakai S, Honda H (2003) Alterations of tumor suppressor genes (Rb, p16, p27 and p53) and an increased FDG uptake in lung cancer. Ann Nucl Med 17:189–196
Seftor RE, Seftor EA, Sheng S, Pemberton PA, Sager R, Hendrix MJ (1998) Maspin suppresses the invasive phenotype of human breast carcinoma. Cancer Res 58:5681–5685
Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA, Hendrix MJ (2002) The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8:2924–2932
Tomizawa Y, Kohno T, Kondo H, Otsuka A, Nishioka M, Niki T, Yamada T, Maeshima A, Yoshimura K, Saito R, Minna JD, Yokota J (2002) Clinicopathological significance of epigenetic inactivation of RASSF1A at 3p21.3 in stage I lung adenocarcinoma. Clin Cancer Res 8:2362–2368
Travis WD, Travis LB, Devesa SS (1995) Lung cancer. Cancer 75:191–202
Wang B, Yan C, Wu Y, Gao H, Wang Q, Jin Y, Huang C, Zhang G, Fu S, Li P (2001) Expression of tumor suppressor genes p16, p21 and p53 in a pair of lung adenocarcinoma cell lines with different metastasis potentials: Anip973 and AGZY83-a. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 18:128–131
Xia W, Lau YK, Hu MC, Li L, Johnston DA, Sheng S, El-Naggar A, Hung MC (2000) High tumoral maspin expression is associated with improved survival of patients with oral squamous cell carcinoma. Oncogene 19:2398–2403
Yasumatsu R, Nakashima T, Hirakawa N, Kumamoto Y, Kuratomi Y, Tomita K, Komiyama S (2001) Maspin expression in stage I and II oral tongue squamous cell carcinoma. Head Neck 23:962–966
Zhang M, Volpert O, Shi YH, Bouck N (2000) Maspin is an angiogenesis inhibitor. Nat Med 6:196–199
Zou Z, Anisowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E, Sager R (1994) Maspin, a serpin with tumor-suppressing activity in human mammary epithelial cells. Science 263:526–529
Zou Z, Gao C, Nagaich AK, Connell T, Saito S, Moul JW, Seth P, Appella E, Srivastava S (2000) p53 regulates the expression of the tumor suppressor gene maspin. J Biol Chem 275:6051–6054
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Nakashima, M., Ohike, N., Nagasaki, K. et al. Prognostic significance of the maspin tumor suppressor gene in pulmonary adenocarcinoma. J Cancer Res Clin Oncol 130, 475–479 (2004). https://doi.org/10.1007/s00432-004-0571-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-004-0571-x